AR123281A1 - Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9 - Google Patents

Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9

Info

Publication number
AR123281A1
AR123281A1 ARP210102325A ARP210102325A AR123281A1 AR 123281 A1 AR123281 A1 AR 123281A1 AR P210102325 A ARP210102325 A AR P210102325A AR P210102325 A ARP210102325 A AR P210102325A AR 123281 A1 AR123281 A1 AR 123281A1
Authority
AR
Argentina
Prior art keywords
compounds useful
substituted bicyclic
bicyclic compounds
tlr9 inhibitors
compounds
Prior art date
Application number
ARP210102325A
Other languages
English (en)
Inventor
David S Yoon
Alicia Regueiro-Ren
Andrew P Degnan
Gang Wu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR123281A1 publication Critical patent/AR123281A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describen compuestos de la fórmula (1), o una sal o profármaco del mismo, en donde X, G, Q¹, Q², R⁵, R⁵ᵃ, y R⁵ᵇ se definen aquí. También se describen métodos para usar tales compuestos como inhibidores de TLR9 y composiciones farmacéuticas que comprenden tales compuestos. Estos compuestos son útiles para tratar, prevenir o retardar enfermedades fibróticas.
ARP210102325A 2020-08-19 2021-08-18 Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9 AR123281A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063067452P 2020-08-19 2020-08-19

Publications (1)

Publication Number Publication Date
AR123281A1 true AR123281A1 (es) 2022-11-16

Family

ID=77693624

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210102325A AR123281A1 (es) 2020-08-19 2021-08-18 Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9

Country Status (13)

Country Link
US (1) US20240067638A1 (es)
EP (1) EP4200297A1 (es)
JP (1) JP2023538393A (es)
KR (1) KR20230053644A (es)
CN (1) CN116096717A (es)
AR (1) AR123281A1 (es)
AU (1) AU2021328575A1 (es)
BR (1) BR112023002737A2 (es)
CA (1) CA3190065A1 (es)
IL (1) IL300727A (es)
MX (1) MX2023001885A (es)
TW (1) TW202227432A (es)
WO (1) WO2022040259A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11807622B2 (en) 2019-01-30 2023-11-07 Insilico Medicine Ip Limited TLR 9 inhibitors
TW202342016A (zh) * 2022-02-18 2023-11-01 美商必治妥美雅史谷比公司 用作tlr9抑制劑之經取代雙環雜芳基化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017058503A1 (en) * 2015-09-29 2017-04-06 Oncotherapy Science, Inc. Bicyclic compound and use thereof for inhibiting suv39h2
US11370794B2 (en) * 2016-11-11 2022-06-28 Dynavax Technologies Corporation Toll-like receptor antagonist compounds and methods of use
WO2018165112A1 (en) * 2017-03-09 2018-09-13 Oncotherapy Science, Inc. Bicyclic compound and use thereof for inhibiting histone methyltransferase
CN114981276A (zh) * 2020-01-09 2022-08-30 住友化学株式会社 杂环化合物和含有其的有害节肢动物防除组合物

Also Published As

Publication number Publication date
MX2023001885A (es) 2023-03-10
IL300727A (en) 2023-04-01
BR112023002737A2 (pt) 2023-03-14
US20240067638A1 (en) 2024-02-29
WO2022040259A1 (en) 2022-02-24
TW202227432A (zh) 2022-07-16
CA3190065A1 (en) 2022-02-24
KR20230053644A (ko) 2023-04-21
CN116096717A (zh) 2023-05-09
EP4200297A1 (en) 2023-06-28
AU2021328575A1 (en) 2023-03-16
JP2023538393A (ja) 2023-09-07

Similar Documents

Publication Publication Date Title
AR123284A1 (es) Compuestos heteroarílicos sustituidos útiles como inhibidores de tlr9
AR123285A1 (es) Compuestos heteroarílicos sustituidos útiles como inhibidores de tlr9
CL2019002204A1 (es) Compuestos inhibidores del vih.
CO2022010460A2 (es) Compuestos tricíclicos sustituidos
CO2022018811A2 (es) Inhibidores de la proteína kras g12c y usos de estos
CL2020001871A1 (es) Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco.
AR123281A1 (es) Compuestos bicíclicos sustituidos útiles como inhibidores de tlr9
PE20181045A1 (es) Compuestos utiles como inmunomoduladores
CO2022002804A2 (es) Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos
UY32582A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero
CL2021001461A1 (es) Moduladores de trex1
CO2019003482A2 (es) Compuestos derivados de ciclobutano o azetidina 1,3 disustituidos como inhibidores de la prostaglandina d sintasa hematopoyética
PE20160180A1 (es) Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos.
CO2019009423A2 (es) Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos
CO2021002976A2 (es) Amidas heterocíclicas de 5 a 7 miembros como inhibidores de jak
CL2019003486A1 (es) Compuestos que contienen nitrogeno sustituido.
AR123424A1 (es) Nuevos compuestos heterocíclicos
CO2023005342A2 (es) Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead para el tratamiento del cancer
CO2023001668A2 (es) Derivados de 1h-benzo[d]imidazol como inhibidores de tlr9 para el tratamiento de fibrosis
MX2022000390A (es) Derivados macrociclicos espirociclicos como inhibidores de mcl-1.
CO2021014210A2 (es) Compuestos de pirrol
BR112022002107A2 (pt) Inibidor de vmat2 e método de preparação para o mesmo e aplicação do mesmo
DOP2021000254A (es) Compuestos de pirrolidina
CO2023004420A2 (es) Compuestos heterocíclicos como inhibidores del bromodominio cbp/ep300
BR112022013488A2 (pt) Pirazolo-pirimidinas substituídas e seu uso